Boston startup lands $28M, closes small biotech buyout; New longevity fund takes shape
Boston-based startup DermBiont has gone back to the venture well while tacking on another small buyout to swell the clinical pipeline.
The startup, which raised …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
